Combined immune checkpoint inhibitor and chemotherapy is effective in a patient with ALK rearranged non-small cell lung cancer: a case report.
Combined immune checkpoint inhibitor and chemotherapy is effective in a patient with ALK rearranged non-small cell lung cancer: a case report.
复制标题
免疫检查点抑制剂联合化疗对 ALK 重排非小细胞肺癌患者有效：病例报告
DOI：
10.21037/tcr.2019.12.39
复制
发表时间：
2020-03
影响因子：
0.9
通讯作者：
Xia Y
中科院分区：
文献类型：
--
作者：
Xia L;Hu H;Li W;Shen H;Xia Y
Targeted therapies are validated to be efficient in non-small cell lung cancer (NSCLC) patients with driver gene mutations, but the emergence and development of immune checkpoint inhibitors (ICIs) in the last decades offers new insight into the therapeutic decisions of patients harboring driver gene mutations. The appropriate application of ICIs-based strategies in these patients remains to be assessed. Here, we present a patient with chest tightness and nonproductive cough. A primary site was found in left lower lobe with pleural effusion, pericardium effusion and multiple enlarged lymph nodes. He was diagnosed with advanced NSCLC and responded well to the first line pembrolizumab combined with pemetrexed and carboplatin with a progression free survival of 26 months. Immunohistochemistry analysis of relapsed 4R lymph node indicated ALK-positive. Surprisingly, identical form of ALK gene rearrangement was observed in re-biopsy sample and the specimen 2 years ago. The patient was again dramatically benefit from 2L alectinib. No adverse event was presented and the progression-free survival is not reached until this case report. Hence, the current case suggested that combined immunotherapy and chemotherapy might be an efficient and tolerable alternative at 1L or after resistance to standard of care in patients with oncogene mutant NSCLC. Further data is required to make this a practical ambition.
登录
查看更多内容
影响因子：
20.4
作者：
Spigel, David R.;Reynolds, Craig;Blumenschein, George, Jr.
通讯作者：
Blumenschein, George, Jr.
影响因子：
158.5
作者：
Solomon, Benjamin J.;Mok, Tony;Waqar, S.
通讯作者：
Waqar, S.
影响因子：
50.5
作者：
Schoenfeld, A. J.;Arbour, K. C.;Hellmann, M. D.
通讯作者：
Hellmann, M. D.
影响因子：
16.6
作者：
Liu, Peng;Zhao, Liwei;Kroemer, Guido
通讯作者：
Kroemer, Guido